drugset / Trial / NCT02777268

Comparison of Pharmacokinetics of Infacort® Versus Immediate-release Hydrocortisone

NCT02777268

Phase 1 Completed 16 enrolled Neurocrine UK Limited Simbec Research · collab
RandomizedCrossoverOpen-labelBasic science

Summary

This was a single centre, open-label, randomised, 5-way crossover study.

Timeline

Start
2013-07
Primary completion
2013-09
Completion
2013-09

Drugs

EvaluationDrugModalityDoseRoute
Comparator Hydrocortisone Other / unclassified 10 mg
Subject Infacort Unknown 0.5 mg
Subject Infacort Unknown 2 mg
Subject Infacort Unknown 5 mg
Subject Infacort Unknown 10 mg

Indications

No indication recorded.